PHARMACYTE BIOTECH, INC. Prepaid Expense and Other Assets, Current
PHARMACYTE BIOTECH, INC. (PMCB) had Prepaid Expense and Other Assets, Current of $32.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-09-14
- 2026-07-31: Prepaid Expense and Other Assets, Current $32.00K.
- 2026-04-30: Prepaid Expense and Other Assets, Current $96.88K.
- 2026-01-31: Prepaid Expense and Other Assets, Current $158.66K.
- 2025-10-31: Prepaid Expense and Other Assets, Current $503.15K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-07-31 | $32.00K 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $96.88K 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $158.66K 10-Q · filed 2026-03-17 | |
| 2025-10-31 | $503.15K 10-Q · filed 2025-12-18 | |
| 2025-07-31 | $238.18K 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $223.76K 10-K · filed 2026-07-29 | |
| 2025-01-31 | $207.36K 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $493.21K 10-Q · filed 2024-12-13 | |
| 2024-07-31 | $240.23K 10-Q · filed 2024-09-17 | |
| 2024-04-30 | $259.80K 10-K · filed 2025-08-11 | |
| 2024-01-31 | $297.76K 10-Q · filed 2024-03-18 | |
| 2023-10-31 | $323.19K 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $88.65K 10-Q · filed 2023-09-18 | |
| 2023-04-30 | $107.68K 10-K · filed 2024-08-13 | |
| 2023-01-31 | $181.01K 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $256.81K 10-Q · filed 2022-12-14 | |
| 2022-07-31 | $28.15K 10-Q · filed 2022-09-14 | |
| 2022-04-30 | $94.17K 10-K · filed 2023-07-31 | |
| 2022-01-31 | $174.10K 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $241.80K 10-Q · filed 2021-12-14 | |
| 2021-07-31 | $549.09K 10-Q · filed 2021-09-14 | |
| 2021-04-30 | $73.13K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $41.71K 10-Q · filed 2021-03-12 | |
| 2020-10-31 | $94.96K 10-Q · filed 2020-12-11 | |
| 2020-07-31 | $136.54K 10-Q · filed 2020-09-11 | |
| 2020-04-30 | $142.78K 10-K · filed 2021-08-10 | |
| 2020-01-31 | $66.95K 10-Q · filed 2020-03-13 | |
| 2019-10-31 | $164.28K 10-Q · filed 2019-12-23 | |
| 2019-07-31 | $149.29K 10-Q · filed 2019-09-13 | |
| 2019-04-30 | $138.15K 10-K · filed 2020-08-13 | |
| 2019-01-31 | $8.48K 10-Q · filed 2019-03-14 | |
| 2018-10-31 | $30.16K 10-Q · filed 2018-12-14 | |
| 2018-07-31 | $120.82K 10-Q · filed 2018-09-12 | |
| 2018-04-30 | $224.07K 10-K · filed 2019-08-13 | |
| 2018-01-31 | $88.39K 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $104.27K 10-Q · filed 2017-12-14 | |
| 2017-07-31 | $117.65K 10-Q · filed 2017-09-13 | |
| 2017-04-30 | $74.27K 10-K · filed 2018-07-20 | |
| 2017-01-31 | $21.68K 10-Q · filed 2017-03-13 | |
| 2016-10-31 | $51.11K 10-Q · filed 2016-12-02 | |
| 2016-07-31 | $54.35K 10-Q · filed 2016-09-06 | |
| 2016-04-30 | $110.03K 10-K · filed 2017-07-27 | |
| 2016-01-31 | $8.42K 10-Q · filed 2016-03-08 | |
| 2015-10-31 | $410.63K 10-Q/A · filed 2016-01-19 | $74.76K 10-Q · filed 2015-12-10 |
| 2015-07-31 | $945.46K 10-Q/A · filed 2016-01-19 | $103.01K 10-Q · filed 2015-08-25 |
| 2015-04-30 | $1.47M 10-K · filed 2016-07-29 | $119.26K 10-K · filed 2015-07-29 |
| 2015-01-31 | $38.18K 10-Q · filed 2015-03-13 | |
| 2014-10-31 | $124.61K 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $172.13K 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $570.11K 10-K/A · filed 2016-01-19 | |
| 2014-01-31 | $675.81K 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $76.05K 10-Q · filed 2013-12-16 | |
| 2013-07-31 | $98.32K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $127.87K 10-K · filed 2014-08-04 | |
| 2013-01-31 | $32.85K 10-Q · filed 2013-03-26 | |
| 2012-10-31 | $68.64K 10-Q · filed 2012-12-26 | |
| 2012-07-31 | $101.72K 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $159.35K 10-K · filed 2013-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |